Helping Conduct Clinical Trials for Psychotic Disorders
The challenges for researchers conducting trials for therapies aimed at psychotic disorders other than schizophrenia are more specialized but no less daunting than those facing researchers focusing on schizophrenia itself. The complexities introduced by mood disorders, dementia, other comorbidities, and environmental factors make it difficult to determine whether an approach you are exploring has any effect on the psychotic disorder you are trying to address. Finding suitable subjects to participate in research can be extraordinarily challenging, as can monitoring participants to ensure both compliance with the protocols associated with your trials and ongoing compliance with any other medications they are supposed to be taking contemporaneously.
How will you manage these challenges? With over 30 years of experience supporting research in psychotic disorders, Worldwide is an internationally acclaimed expert in clinical trial management. We offer full-service Phase I–Phase IV and real-world evidence clinical research services for studies into the full spectrum of psychotic disorders. We have long-established relationships both with teaching hospitals and community mental health facilities that can help you gain insight into the efficacy of the therapy you are developing.
Our customers know that with Worldwide Clinical Trials they will receive a stable project team of professionals with deep experience in psychiatric and CNS research. They turn to the Worldwide team for insightful feedback on development plans, for detailed and expert feasibility analyses, and for the resources and management skills to deliver a project on time and on budget.